Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Sangamo Announces FDA Acceptance of IND Application for ST-920 Gene Therapy Candidate

americanpharmaceuticalreviewFebruary 21, 2019

Tag: FDA , ERT , Sangamo , ST-920

PharmaSources Customer Service